| Structure |
Chemical Name |
CAS |
MF |
 |
Benzene, 1-fluoro-5-methoxy-2-methyl-4-nitro- (9CI) |
314298-13-0 |
C8H8FNO3 |
 |
Benzenamine, 6-bromo-3-methyl-2-nitro- |
859791-84-7 |
C7H7BrN2O2 |
 |
N-(4-Methoxyphenyl)-4-methylbenzenamine |
39253-43-5 |
C14H15NO |
 |
N,N'-propanediylidenedianiline |
5652-79-9 |
C15H14N2 |
 |
Crystal Lafite |
|
|
 |
Chemical reagents 1.10-phenanthroline |
|
|
 |
4,5-Methphenanthrene |
|
|
 |
4,7-Diphenyl-1,10-phenanthroline solution |
|
|
 |
Filodipine |
|
|
 |
1,10phenanthroline anhydrate |
|
|
 |
Sorafenib Impurity INT-2-G |
|
|
 |
2,9-Dimethyl-4,7-di(4-pyridyl)-1,10-phenanthroline |
|
|
 |
Avanafil Impurity 87 |
|
|
 |
Phenanthrene-D10 1517-22-2 Standard |
|
|
 |
4-octyl-N-phenylaniline |
4175-37-5 |
C20H27N |
 |
4,7-Diphenyl 1,10-Phenanthroline |
|
|
 |
O-phenanthroline hydrochloride monohydrate |
|
|
 |
Finasau |
|
|
![Ruthenium(2+), (11,12-dimethyldipyrido[3,2-a:2',3'-c]phenazine-κN4,κN5)bis(1,10-phenanthroline-κN1,κN10)-,(OC-6-22)-](/CAS/20211123/GIF/142211-64-1.gif) |
Ruthenium(2+), (11,12-dimethyldipyrido[3,2-a:2',3'-c]phenazine-κN4,κN5)bis(1,10-phenanthroline-κN1,κN10)-,(OC-6-22)- |
142211-64-1 |
C44H30N8Ru+2 |
 |
Benzenamine, 3-ethoxy-N-phenyl- (9CI) |
43035-14-9 |
C14H15NO |
 |
2-Phenyl-1,10-phenanthroline |
|
|
 |
8-Fluoro-9-(3-hydroxypropionyl)-3-methyl-6-oxo-2,3-dihydro-6H-1-oxo-3A-azaphenanthroline-5-carboxylic acid Pazufloxacin impurity D-3 |
|
|
 |
Diphenylamine and diisobutylene condensation products |
|
|
 |
Hexanitrodiphenylamine |
|
C12H5N7O12 |
 |
Test ferrous iron (1,10-phenanthroline) indicator solution test solution |
|
|
 |
9,9-dimethylcarbazine |
6267-02-3 |
C15H15N |
 |
Regorafenib impurity 07 |
1111302-57-8 |
C25H22FN5O |
 |
O-phenanthroline solution |
|
|
 |
2-METHYLDIPHENYLAMINE |
1205-39-6 |
C13H13N |
![(8R,9S,13S,16R,17R)-3,16-dihydroxy-13-methyl-7,8,9,11,12,13,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl acetate](/) |
(8R,9S,13S,16R,17R)-3,16-dihydroxy-13-methyl-7,8,9,11,12,13,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl acetate |
|
|
 |
4,4'-DIMETHOXYDIPHENYLAMINE |
101-70-2 |
C14H15NO2 |
 |
2'-CHLORO-4-DIMETHYLAMINOAZOBENZENE |
3010-47-7 |
C14H14ClN3 |
 |
Diphenyl aMine chloride |
|
C12H10ClN |
 |
151386-72-0 |
151386-72-0 |
|
 |
N,N-DIMETHYL-4,4'-AZODIANILINE |
539-17-3 |
C14H16N4 |
 |
(S)-3-(1-AMINOETHYL)BENZENAMINE |
317830-29-8 |
C8H12N2 |
 |
Regorafenib Impurity 8 |
|
|
 |
2, 7-dihydroxy-4, 6-dimethoxy phenanthrene |
108352-70-1 |
C16H14O4 |
![1-[(2-Chlorophenyl)-N-(methylimino)methyl]cyclopentanol hydrochloride](/CAS/GIF/90717-16-1.gif) |
1-[(2-Chlorophenyl)-N-(methylimino)methyl]cyclopentanol hydrochloride |
90717-16-1 |
C13H17Cl2NO |
 |
1,10 ferolin |
|
|
 |
Methyltetrahydrophenanthrone |
|
|
 |
Fexofenadine hydrochloride |
|
|
 |
Reagent 1.10-phenanthroline |
|
|
 |
4,7-Di(1-pyrene)-2,9-dimethyl-1,10-phenanthroline |
|
|
 |
Diphenylamine-4-sulfonic acid water solution 33% |
|
C12H11NO3S |
 |
4,4'-(1,6-Hexanediyl)dioxydianiline |
47244-09-7 |
C18H24N2O2 |
![Carfilzomib/Carfilzomib intermediate/247068-82-2[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]carbamic acid tert-butyl ester](/) |
Carfilzomib/Carfilzomib intermediate/247068-82-2[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]carbamic acid tert-butyl ester |
|
|
 |
chemicalbookcheck |
9009-00-1 |
|
 |
Nafurafil-6A amine |
|
|
 |
2,2-dihydroxydiphenylamine |
|
C12H12NO2 |
 |
Dicumyldiphenylamine |
|
C30H31N |
 |
Phytin Special Resin |
|
|
 |
Regorafenib Impurity 41 |
|
|
 |
2-CHLORO-9-PHENYL-1,10-PHENANTHROLINE |
|
|
 |
Efinaconazole Impurity 31 |
|
|
![Iridium-(1,10-phenanthroline-κN1,κN10)bis[5-(1,1-dimethylethyl)-2-[4-(1,1-dimethylethyl)-2-pyridinyl-κN]phenyl-κC]-(OC-6-33)-hexafluorophosphate](/CAS/20211123/GIF/2828437-80-3.gif) |
Iridium-(1,10-phenanthroline-κN1,κN10)bis[5-(1,1-dimethylethyl)-2-[4-(1,1-dimethylethyl)-2-pyridinyl-κN]phenyl-κC]-(OC-6-33)-hexafluorophosphate |
2828437-80-3 |
C50H56F6IrN4P |
 |
(4-Chlorophenyl)diphenylamine |
4316-56-7 |
C18H14ClN |
 |
9-(2,3-Dihydroxypropionyl)-8-fluoro-3-methyl-6-oxo-2,3-dihydro-6H-1-oxo-3A-azaphenanthroline-5-carboxylic acid Pazufloxacin impurity D-2 |
|
|
 |
Feigrisolide A,B,C,D |
|
|
 |
Fiscalin |
|
|
 |
4-Fluoro-4'-nitrodiphenylamine |
330-89-2 |
C12H9FN2O2 |
 |
2,4-fluoro-4'-nitrodiphenylamine
|
|
|
![1,10-Phenanthroline, 2,9-dimethyl-4-[1,1′:3′,1′′-terphenyl]-5′-yl-](/CAS/20240320/GIF/2757250-34-1.gif) |
1,10-Phenanthroline, 2,9-dimethyl-4-[1,1′:3′,1′′-terphenyl]-5′-yl- |
2757250-34-1 |
C32H24N2 |
 |
10-Chloro-2-phenylphenanthrenyl(3,4-D)oxazole(R5236) |
|
|
![(8R,9S,13S,14S,15S,16S,17S)-3-(benzyloxy)-15,16-dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate](/) |
(8R,9S,13S,14S,15S,16S,17S)-3-(benzyloxy)-15,16-dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate |
|
|
 |
4-(1H-1,2,4-Triazol-1-ylmethyl)aniline |
119192-10-8 |
C9H10N4 |
 |
2-bromo-N-methyl-6-nitrobenzenamine |
1004618-77-2 |
C7H7BrN2O2 |
![Benzenamine, 4,4'-[1,4-phenylenebis(thio)]bis-](/CAS/20180527/GIF/17619-11-3.gif) |
Benzenamine, 4,4'-[1,4-phenylenebis(thio)]bis- |
17619-11-3 |
C18H16N2S2 |
 |
4-CHLORO-M-XYLENE |
95-66-9 |
C8H9Cl |
 |
4,4'-(2,2-bis(4-bromophenyl)ethene-1,1-diyl)bis(N,N-diphenylaniline) |
1637286-30-6 |
C50H36Br2N2 |
 |
4-METHOXYDIPHENYLAMINE |
1208-86-2 |
C13H13NO |
 |
2,2'-Dinitrodiphenylamine |
18264-71-6 |
C12H9N3O4 |
 |
4.4'-DIAMINODIPHENYLAMINESULFATE |
6369-04-6 |
C12H15N3O4S |
 |
4,4'-Dimethyltriphenylamine |
20440-95-3 |
C20H19N |
 |
Regorafenib Impurity 9 |
|
|
 |
N,N'-Di(1-naphthyl)-4,4'-benzidine |
152670-41-2 |
C32H24N2 |
![Bis(2,2'-bipyridyl)(4,5,9,14-Tetraaza-benzo[b]triphenylene)iridium(III) dichloride](/) |
Bis(2,2'-bipyridyl)(4,5,9,14-Tetraaza-benzo[b]triphenylene)iridium(III) dichloride |
|
|
![9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene](/CAS/20210305/GIF/1369431-34-4.gif) |
9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene |
1369431-34-4 |
C34H21Cl |
 |
N-methyl-2,4-dinitroaniline |
2044-88-4 |
C7H7N3O4 |
 |
N-phenyl-3-(trifluoromethyl)aniline |
101-23-5 |
C13H10F3N |
![4,7-Dibromo-[1,10]-phenanthroline](/) |
4,7-Dibromo-[1,10]-phenanthroline |
|
|
 |
1,10-Phenanthroline anhydrate |
|
|
 |
2,9-Dimethyl-phenanthroline |
|
|
 |
Caffeine |
|
|
 |
Anhydrous phenanthroline |
|
|
 |
(3,5-diphenyl-9-ylphenyl) chlorobenzene |
|
|
![Iridium-(1,10-phenanthroline-κN1,κN10)bis[3,5-difluoro-2-(5-methyl-2-pyridinyl-κN)phenyl-κC]-hexafluorophosphate](/CAS/20211123/GIF/2828437-75-6.gif) |
Iridium-(1,10-phenanthroline-κN1,κN10)bis[3,5-difluoro-2-(5-methyl-2-pyridinyl-κN)phenyl-κC]-hexafluorophosphate |
2828437-75-6 |
C36H24F10IrN4P |
 |
Carfilzomib/Carfilzomib/868540-17-4 |
|
|
 |
Sanglifehrin A-D |
|
|
 |
Regofini impurity hd1913-6 |
|
|
![1,3,5-triazine, 2-[3-(2-chloro-10-phenyl-9-phenanthroline) phenyl ] -4,6-diphenyl -](/CAS/20211123/GIF/2457202-55-8.gif) |
1,3,5-triazine, 2-[3-(2-chloro-10-phenyl-9-phenanthroline) phenyl ] -4,6-diphenyl - |
2457202-55-8 |
C41H26ClN3 |
 |
4,4-distyrenated diphenylamine |
|
|
 |
9,10-Dihydro-10-(2′,5′-diallyloxyphenyl)-9-oxa-10-phosphaphenanthrene-10-oxide |
810681-08-4 |
C24H21O4P |
 |
1,10-phenanthroline-3,8-diamine hydrochloride |
|
|
![(8R,9S,13S,14S,15S,16S,17R)-3-(benzyloxy)-15,16-dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate](/) |
(8R,9S,13S,14S,15S,16S,17R)-3-(benzyloxy)-15,16-dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate |
|
|
![(8R,9S,13S,14S,15R,16R,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,15,16,17-tetraol](/) |
(8R,9S,13S,14S,15R,16R,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,15,16,17-tetraol |
|
|
 |
2,4-Dimethyldiphenylamine |
25078-04-0 |
C14H15N |
 |
DiphenylaMMoniuM Methanesulfonate |
|
C13H15NO3S |
 |
N-(2-nitrophenyl)-2-fluoroaniline |
28898-02-4 |
C12H9FN2O2 |
 |
4-DIAZO-4'-METHOXYDIPHENYLAMINE SULFATE |
49732-38-9 |
C13H13N3O5S |